JPMorgan Chase & Co. Reduces Stake in Ingredion Incorporated $INGR

JPMorgan Chase & Co. lowered its stake in Ingredion Incorporated (NYSE:INGR) by 7.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 393,923 shares of the company’s stock after selling 31,410 shares during the quarter. JPMorgan Chase & Co.’s holdings in Ingredion were worth $48,102,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the stock. Integrated Wealth Concepts LLC increased its position in shares of Ingredion by 32.8% during the first quarter. Integrated Wealth Concepts LLC now owns 2,082 shares of the company’s stock valued at $281,000 after buying an additional 514 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Ingredion by 63.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,694 shares of the company’s stock valued at $499,000 after acquiring an additional 1,440 shares in the last quarter. NewEdge Advisors LLC increased its holdings in Ingredion by 9.0% during the 1st quarter. NewEdge Advisors LLC now owns 9,687 shares of the company’s stock worth $1,310,000 after acquiring an additional 797 shares during the period. Goldman Sachs Group Inc. increased its holdings in Ingredion by 5.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 101,414 shares of the company’s stock worth $13,712,000 after acquiring an additional 5,255 shares during the period. Finally, Focus Partners Wealth lifted its stake in Ingredion by 5.6% in the 1st quarter. Focus Partners Wealth now owns 3,636 shares of the company’s stock worth $492,000 after purchasing an additional 192 shares in the last quarter. Hedge funds and other institutional investors own 85.27% of the company’s stock.

Ingredion Price Performance

INGR opened at $109.18 on Friday. The company’s 50-day simple moving average is $115.76 and its two-hundred day simple moving average is $115.43. Ingredion Incorporated has a 52-week low of $102.31 and a 52-week high of $141.78. The stock has a market capitalization of $6.87 billion, a P/E ratio of 9.78, a P/E/G ratio of 0.87 and a beta of 0.69. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.73 and a current ratio of 2.66.

Ingredion (NYSE:INGR) last released its quarterly earnings data on Tuesday, February 3rd. The company reported $2.53 earnings per share for the quarter, missing the consensus estimate of $2.59 by ($0.06). Ingredion had a net margin of 10.10% and a return on equity of 17.32%. The company had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.78 billion. During the same period in the previous year, the firm earned $2.63 earnings per share. The firm’s revenue for the quarter was down 2.4% on a year-over-year basis. Ingredion has set its FY 2026 guidance at 11.000-11.8 EPS. As a group, analysts predict that Ingredion Incorporated will post 11.14 EPS for the current year.

Ingredion Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 21st. Stockholders of record on Wednesday, April 1st will be paid a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date is Wednesday, April 1st. Ingredion’s dividend payout ratio (DPR) is 29.39%.

Insider Buying and Selling

In other Ingredion news, VP Davida Marie Gable sold 375 shares of the business’s stock in a transaction dated Wednesday, March 18th. The stock was sold at an average price of $112.44, for a total transaction of $42,165.00. Following the completion of the sale, the vice president directly owned 7,110 shares in the company, valued at $799,448.40. The trade was a 5.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Larry Fernandes sold 1,125 shares of the company’s stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $116.55, for a total transaction of $131,118.75. Following the sale, the senior vice president directly owned 30,514 shares of the company’s stock, valued at $3,556,406.70. The trade was a 3.56% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 48,685 shares of company stock valued at $5,783,898 over the last 90 days. Company insiders own 2.30% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have commented on INGR shares. UBS Group raised their price target on shares of Ingredion from $119.00 to $124.00 and gave the company a “neutral” rating in a report on Thursday, February 5th. Zacks Research raised shares of Ingredion from a “strong sell” rating to a “hold” rating in a report on Monday, December 22nd. BMO Capital Markets reissued a “market perform” rating on shares of Ingredion in a research note on Wednesday, February 4th. Barclays boosted their target price on Ingredion from $124.00 to $128.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 4th. Finally, Stephens restated an “equal weight” rating and issued a $120.00 target price on shares of Ingredion in a research note on Wednesday, February 4th. Two equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $126.43.

Key Stories Impacting Ingredion

Here are the key news stories impacting Ingredion this week:

• Positive Sentiment: Ingredion was named one of the 2026 “World’s Most Ethical Companies,” a reputational win that can support investor confidence and appeal to ESG-focused funds. Ingredion Named One of the 2026 World’s Most Ethical Companies
• Positive Sentiment: Ingredion formed an alliance with Shiru to use AI-designed proteins, signaling a strategic push into higher-value nutrition and specialty ingredients that could lift long‑term margins if commercialization succeeds. Ingredion Taps Shiru AI Proteins To Shift Toward Higher Value Nutrition
• Positive Sentiment: Analyst and thematic attention: Zacks highlighted Ingredion among three AgTech/food-innovation picks, reinforcing the narrative that the company is moving beyond commodity starch/sweetener exposure toward science-driven growth. 3 AgTech & Food Innovation Picks Riding on Structural Growth Trends
• Positive Sentiment: Benchmark initiated coverage with a Buy rating and $130 target, adding incremental buy-side analyst support that may underpin upside if results improve. Ingredion (NYSE:INGR) Coverage Initiated at Benchmark
• Positive Sentiment: Dividend: the board declared a $0.82 quarterly dividend (annualized $3.28, ~3.0% yield), supporting income investors and signaling cash-flow confidence.
• Negative Sentiment: Insider selling: VP Davida Marie Gable sold 375 shares at about $112.44 on March 18; while a small dollar amount, insider sales can be read negatively by short‑term traders. Davida Marie Gable Sells 375 Shares of Ingredion (NYSE:INGR) Stock

About Ingredion

Ingredion Incorporated is a global ingredient solutions company specializing in the production and sale of starches, sweeteners, nutrition ingredients and biomaterials derived primarily from corn and other plant-based raw materials. The company serves a diverse set of industries, including food and beverage, brewing, pharmaceuticals and personal care, providing functional ingredients that enhance texture, stability, flavor and nutritional value in a wide array of end products.

The company’s product portfolio comprises native and modified starches, high-fructose corn syrup, dextrose, maltodextrins, specialty sweeteners and various texturizers.